A year has 8,760 hours. Support the campaign
Vitruvian Shield
AI Analytics

AI analytics for clinical trials

The AI Analytics module is in development, and so is every AI capability described on this page. Clinical-decision-support AI is held on a 2027–2029 timeline, gated on 500+ patients and 6–12 months of longitudinal data per indication.

What the AI capabilities are designed to do

Each capability below is in development. None is used for clinical decisions today.

Predictive enrolment forecasting

In development: machine-learning models that use historical enrolment patterns, site performance and external factors to forecast enrolment timelines with confidence intervals.

Adverse-event detection

In development: natural-language processing of clinical narratives, with lab results and vital-sign data, to flag potential adverse events and safety signals for investigator review.

Protocol-deviation prediction

In development: risk scoring that identifies sites and patients at risk of protocol deviations, so monitoring can be targeted.

Data-quality scoring

In development: data-quality assessment across modules that flags systematic entry errors, site-level anomalies and cross-form inconsistencies.

Patient stratification

In development: unsupervised clustering and biomarker analysis to identify patient subgroups and response patterns that can inform adaptive designs.

Automated signal detection

In development: continuous statistical monitoring with Bayesian and frequentist methods for efficacy, futility and safety signals, with configurable stopping rules.

AI outputs prepared for regulatory review

In development: model transparency reports, feature-importance rankings and validation metrics attached to each AI-generated insight, formatted for regulatory review and audit inspection.

How it works

How the analytics module handles study data, from ingestion to reporting.

1

Ingest and prepare

Data from the platform modules (EDC, RPM, ePRO and CTMS) flows into the analytics environment without manual ETL.

2

Analyse and predict

In development: pre-trained and custom models running against study data, with predictive dashboards, anomaly alerts and risk scores.

3

Report and act

In development: AI analysis reports with model transparency, for export to safety committees, DMCs and regulatory submission packages.

See it in action

AI Assistant — Chatbot Feature

Patient-facing AI chatbot for protocol adherence and symptom triage, in development.

Talk to us about your next study

Tell us about the protocol, the countries and the devices. We will show you how the platform would run it.